-
1
-
-
0142060245
-
Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay
-
Andersson N, Klint S, Randwell G et al. Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay. Am J Respir Crit Care Med 1994; 149 (Suppl 4): A467.
-
(1994)
Am J Respir Crit Care Med
, vol.149
, Issue.4 SUPPL.
-
-
Andersson, N.1
Klint, S.2
Randwell, G.3
-
2
-
-
0029075287
-
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma
-
Ayres JG, Bateman ED, Lundbäck B, Harris TAJ, on Behalf of an International Study Group. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Resp J 1995; 8: 579-586.
-
(1995)
Eur Resp J
, vol.8
, pp. 579-586
-
-
Ayres, J.G.1
Bateman, E.D.2
Lundbäck, B.3
Harris, T.A.J.4
-
3
-
-
0000920267
-
A comparison of fluticasone propionate via Diskus™ (Accuhaler™) inhaler and budesonide via Turbuhaler™ inhaler in adult asthmatics
-
Backman R, Pickering CAC, Baumgarten C, Huskisson SC. A comparison of fluticasone propionate via Diskus™ (Accuhaler™) inhaler and budesonide via Turbuhaler™ inhaler in adult asthmatics. J Allergy Clin Immunol 1996; 97: 249.
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 249
-
-
Backman, R.1
Pickering, C.A.C.2
Baumgarten, C.3
Huskisson, S.C.4
-
4
-
-
0027288321
-
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma
-
Barnes NC, Marone G, DiMaria GU et al. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir J 1993; 6: 877-884.
-
(1993)
Eur Respir J
, vol.6
, pp. 877-884
-
-
Barnes, N.C.1
Marone, G.2
DiMaria, G.U.3
-
5
-
-
0031888153
-
Clinical experience with fluticasone propionate in asthma: A meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less
-
Barnes NC, Hallett C, Harris TAJ. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998; 92: 95-104.
-
(1998)
Respir Med
, vol.92
, pp. 95-104
-
-
Barnes, N.C.1
Hallett, C.2
Harris, T.A.J.3
-
6
-
-
9344259603
-
The effect of inhaled fluticasone propionate (FP), a new potent corticosteroid in severe asthma
-
Bauer K, Bantje TA, Sips AP et al. The effect of inhaled fluticasone propionate (FP), a new potent corticosteroid in severe asthma. Eur Respir J 1988; 1 (Suppl 2): 201s.
-
(1988)
Eur Respir J
, vol.1
, Issue.2 SUPPL.
-
-
Bauer, K.1
Bantje, T.A.2
Sips, A.P.3
-
7
-
-
0024543839
-
A self-management plan in the treatment of adult asthma
-
Beasley R, Cushley M, Holgate ST. A self-management plan in the treatment of adult asthma. Thorax 1989; 44: 200-204.
-
(1989)
Thorax
, vol.44
, pp. 200-204
-
-
Beasley, R.1
Cushley, M.2
Holgate, S.T.3
-
8
-
-
13044262065
-
A six month comparison of the efficacy of high dose fluticasone propionate (FP) with beclomethasone dipropionate (BDP) and budesonide (BUD) in adults with severe asthma
-
Berend N. A six month comparison of the efficacy of high dose fluticasone propionate (FP) with beclomethasone dipropionate (BDP) and budesonide (BUD) in adults with severe asthma. Eur Respir J 1997; 10 (Suppl 25): 105s.
-
(1997)
Eur Respir J
, vol.10
, Issue.25 SUPPL.
-
-
Berend, N.1
-
9
-
-
0024893189
-
Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: A multicentre, double-blind, group comparative trial
-
Bianco S, del Bono N, Grassi V et al. Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: a multicentre, double-blind, group comparative trial. Respiration 1989; 56: 204-211.
-
(1989)
Respiration
, vol.56
, pp. 204-211
-
-
Bianco, S.1
Del Bono, N.2
Grassi, V.3
-
10
-
-
0024322527
-
Comparison of dose-response eflects of inhaled beclomethasone dipropionate and budesonide in the management of asthma
-
Boe J, Rosenhall L, Alton M et al. Comparison of dose-response eflects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 1989; 44: 349-355.
-
(1989)
Allergy
, vol.44
, pp. 349-355
-
-
Boe, J.1
Rosenhall, L.2
Alton, M.3
-
11
-
-
0028576801
-
High dose inhaled steroids in asthmatics: Moderate efficacy gain and suppression of the hypothalamus-pituitary-adrenal (HPA) axis
-
Boe J, Bakke P, Rødølen T et al. High dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamus-pituitary-adrenal (HPA) axis. Eur Respir J 1994; 7: 2179-2184.
-
(1994)
Eur Respir J
, vol.7
, pp. 2179-2184
-
-
Boe, J.1
Bakke, P.2
Rødølen, T.3
-
12
-
-
4244026898
-
Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in the peripheral blood of patients with asthma
-
Bootsma GP, Dekhuijzen PNR, Festen J, van Herwaarded CLA. Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in the peripheral blood of patients with asthma. Am J Respir Crit Care Med 1995a; 151: A387.
-
(1995)
Am J Respir Crit Care Med
, vol.151
-
-
Bootsma, G.P.1
Dekhuijzen, P.N.R.2
Festen, J.3
Van Herwaarded, C.L.A.4
-
13
-
-
8244235867
-
Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness
-
Bootsma GP, Dekhuijzen PNR, Festen J, van Herwaarded CLA. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness. Am J Respir Crit Care Med 1995b; 151: A275.
-
(1995)
Am J Respir Crit Care Med
, vol.151
-
-
Bootsma, G.P.1
Dekhuijzen, P.N.R.2
Festen, J.3
Van Herwaarded, C.L.A.4
-
14
-
-
4243861538
-
Clinical equivalence of once vs twice daily administration of inhaled fluticasone propionate in the treatment of mild and moderate asthma
-
Boulet LP, Robson R, Stepner N, for the International Study Group. Clinical equivalence of once vs twice daily administration of inhaled fluticasone propionate in the treatment of mild and moderate asthma. Eur Resp J 1996; 9 (Suppl 23): 52s.
-
(1996)
Eur Resp J
, vol.9
, Issue.23 SUPPL.
-
-
Boulet, L.P.1
Robson, R.2
Stepner, N.3
-
15
-
-
4243811080
-
Double-blind parallel group study to compare the long term clinical efficacy and safety of two different methods of administering inhaled fluticasone propionate in chronic severe asthmatic patients
-
Bousquet J, Tisserand B, Medley HV. Double-blind parallel group study to compare the long term clinical efficacy and safety of two different methods of administering inhaled fluticasone propionate in chronic severe asthmatic patients. Eur Resp J 1995; 8 (Suppl 19): 427s.
-
(1995)
Eur Resp J
, vol.8
, Issue.19 SUPPL.
-
-
Bousquet, J.1
Tisserand, B.2
Medley, H.V.3
-
16
-
-
0002537669
-
Design, manufacture and dose consistency of the Serevent Diskus inhaler
-
Brindley A, Sumby BS, Smith IJ et al. Design, manufacture and dose consistency of the Serevent Diskus inhaler. Pharm Tech Eur 1995; 7: 14-22.
-
(1995)
Pharm Tech Eur
, vol.7
, pp. 14-22
-
-
Brindley, A.1
Sumby, B.S.2
Smith, I.J.3
-
17
-
-
0027406017
-
Guidelines on the management of asthma
-
British Thoracic Society. Guidelines on the management of asthma. Thorax 1993; 48 (Suppl 1): S1-S24.
-
(1993)
Thorax
, vol.48
, Issue.1 SUPPL.
-
-
-
18
-
-
0031034624
-
The British guidelines on asthma management. 1995 Review and position statement
-
British Thoracic Society. The British guidelines on asthma management. 1995 Review and position statement. Thorax 1997; 52 (Suppl): S1-S21.
-
(1997)
Thorax
, vol.52
, Issue.SUPPL.
-
-
-
19
-
-
0028150916
-
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
-
Chervinsky P, van As A, Bronsky EA et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994a; 94: 676-683.
-
(1994)
J Allergy Clin Immunol
, vol.94
, pp. 676-683
-
-
Chervinsky, P.1
Van As, A.2
Bronsky, E.A.3
-
20
-
-
26844445795
-
Gender does not affect ability of fluticasone propionate aerosol to reduce oral prednisolone dose in severe asthma
-
Chervinsky P, Cook CK, Kellerman DJ, Kral KM. Gender does not affect ability of fluticasone propionate aerosol to reduce oral prednisolone dose in severe asthma. Allergy Clin Immunol News 1994b; Suppl 1: 20.
-
(1994)
Allergy Clin Immunol News
, vol.1
, Issue.SUPPL.
, pp. 20
-
-
Chervinsky, P.1
Cook, C.K.2
Kellerman, D.J.3
Kral, K.M.4
-
21
-
-
26844540988
-
Fluticasone propionate 500 mcg/day is superior to triamcinolone acetonide 800 mcg/day in controlling asthma
-
Chervinsky P, Ginchansky E, Ayars G et al. Fluticasone propionate 500 mcg/day is superior to triamcinolone acetonide 800 mcg/day in controlling asthma. Eur Respir J 1996; 9 (Suppl 23): 78s.
-
(1996)
Eur Respir J
, vol.9
, Issue.23 SUPPL.
-
-
Chervinsky, P.1
Ginchansky, E.2
Ayars, G.3
-
22
-
-
0016756721
-
Importance of dosage in local steroid treatment for asthma
-
Clark TJH. Importance of dosage in local steroid treatment for asthma. Foli Allergol Immunol Clin 1975; 22: 232.
-
(1975)
Foli Allergol Immunol Clin
, vol.22
, pp. 232
-
-
Clark, T.J.H.1
-
23
-
-
4243386447
-
Fluticasone propionate administered via the Diskus 500 μg once daily or 250 μg twice daily is safe and effective in adult patients with asthma
-
Clifford DP, Adelglass R, ZuWallack R et al. Fluticasone propionate administered via the Diskus 500 μg once daily or 250 μg twice daily is safe and effective in adult patients with asthma. Am J Respir Crit Care Med 1997; 155: A349.
-
(1997)
Am J Respir Crit Care Med
, vol.155
-
-
Clifford, D.P.1
Adelglass, R.2
Zuwallack, R.3
-
25
-
-
0026087034
-
Paradoxical bronchospasm after use of inhalation aerosols: A review of the literature
-
Cocchetto DM, Sykes RS, Spector S. Paradoxical bronchospasm after use of inhalation aerosols: a review of the literature. J Asthma 1991; 28: 49-53.
-
(1991)
J Asthma
, vol.28
, pp. 49-53
-
-
Cocchetto, D.M.1
Sykes, R.S.2
Spector, S.3
-
26
-
-
0030882724
-
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
-
Condemi JJ, Chervinsky P, Goldstein MF et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol 1997; 100: 467-474.
-
(1997)
J Allergy Clin Immunol
, vol.100
, pp. 467-474
-
-
Condemi, J.J.1
Chervinsky, P.2
Goldstein, M.F.3
-
27
-
-
0000379674
-
A comparison of fluticasone propionate 100 μg twice daily with budesonide 200 μg twice daily via their respective powder devices in the treatment of mild asthma
-
Connolly A, on Behalf of a UK Study Group. A comparison of fluticasone propionate 100 μg twice daily with budesonide 200 μg twice daily via their respective powder devices in the treatment of mild asthma. Eur J Clin Res 1995; 7: 15-29.
-
(1995)
Eur J Clin Res
, vol.7
, pp. 15-29
-
-
Connolly, A.1
-
28
-
-
0016292471
-
Response of patients receiving high dose beclomethasone dipropionate
-
Costello JF, Clark TJH. Response of patients receiving high dose beclomethasone dipropionate. Thorax 1974; 29: 571-573.
-
(1974)
Thorax
, vol.29
, pp. 571-573
-
-
Costello, J.F.1
Clark, T.J.H.2
-
29
-
-
26844544580
-
Improvement in general quality of life for asthmatics receiving inhaled fluticasone propionate (FP) 500 μg/day versus triamcinolone acetonide (TAA) 800 μg/day or placebo (PL)
-
Cox FM, Goodwin B, Cohen R, Rogenes P, Misniewski M. Improvement in general quality of life for asthmatics receiving inhaled fluticasone propionate (FP) 500 μg/day versus triamcinolone acetonide (TAA) 800 μg/day or placebo (PL). Eur Resp J 1996a; 9 (Suppl 23): 80s.
-
(1996)
Eur Resp J
, vol.9
, Issue.23 SUPPL.
-
-
Cox, F.M.1
Goodwin, B.2
Cohen, R.3
Rogenes, P.4
Misniewski, M.5
-
30
-
-
2642604749
-
Superior impact of inhaled fluticasone propionate 500 μg/day vs. triamcinolone acetonide 800 μg/day or placebo on asthma-specific quality of life in asthmatics
-
Cox FM, Goodwin B, Pepsin P et al. Superior impact of inhaled fluticasone propionate 500 μg/day vs. triamcinolone acetonide 800 μg/day or placebo on asthma-specific quality of life in asthmatics. Am J Respir Crit Care Med 1996b; 153: A340.
-
(1996)
Am J Respir Crit Care Med
, vol.153
-
-
Cox, F.M.1
Goodwin, B.2
Pepsin, P.3
-
31
-
-
15144348812
-
Evaluation of general quality of life using the SF-36 in asthmatics receiving inhaled fluticasone propionate 500 μg/day, triamcinolone acetonide 800 μg/day or placebo
-
Cox FM, Goodwin B, Pepsin P et al. Evaluation of general quality of life using the SF-36 in asthmatics receiving inhaled fluticasone propionate 500 μg/day, triamcinolone acetonide 800 μg/day or placebo. Am J Respir Crit Care Med 1996c; 153: A801.
-
(1996)
Am J Respir Crit Care Med
, vol.153
-
-
Cox, F.M.1
Goodwin, B.2
Pepsin, P.3
-
32
-
-
0027491554
-
A dose-ranging study of fluticasone propionate in adult patients with moderate asthma
-
Dahl R, Lundbäck B, Malo J-L et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993; 104: 1352-1358.
-
(1993)
Chest
, vol.104
, pp. 1352-1358
-
-
Dahl, R.1
Lundbäck, B.2
Malo, J.-L.3
-
33
-
-
13044306281
-
The safety and efficacy of fluticasone propionate 200 μg daily given via the Diskhaler inhaler as compared with the pressurised metered dose inhaler in adult asthma
-
Dahl R, on Behalf of an International Group. The safety and efficacy of fluticasone propionate 200 μg daily given via the Diskhaler inhaler as compared with the pressurised metered dose inhaler in adult asthma. Clin Exp Allergy 1993; 23 (Suppl 1): 81.
-
(1993)
Clin Exp Allergy
, vol.23
, Issue.1 SUPPL.
, pp. 81
-
-
Dahl, R.1
-
34
-
-
0016746139
-
Pharmacokinetics of inhaled substances
-
Davies DS. Pharmacokinetics of inhaled substances. Postgrad Med J 1975; 51 (Suppl 7): 69-75.
-
(1975)
Postgrad Med J
, vol.51
, Issue.7 SUPPL.
, pp. 69-75
-
-
Davies, D.S.1
-
35
-
-
0022498062
-
A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in steroid-dependent patients
-
Dorrow P. A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in steroid-dependent patients. Eur J Respir Dis 1986; 69 (Suppl 147): 317-319.
-
(1986)
Eur J Respir Dis
, vol.69
, Issue.147 SUPPL.
, pp. 317-319
-
-
Dorrow, P.1
-
36
-
-
0027509447
-
The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma
-
Edwards AM, Stevens MT. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J 1993; 6: 35-41.
-
(1993)
Eur Respir J
, vol.6
, pp. 35-41
-
-
Edwards, A.M.1
Stevens, M.T.2
-
37
-
-
0027162055
-
Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year
-
Fabbri L, Burge PS, Croonenborgh L et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993; 48: 817-823.
-
(1993)
Thorax
, vol.48
, pp. 817-823
-
-
Fabbri, L.1
Burge, P.S.2
Croonenborgh, L.3
-
38
-
-
0023036808
-
A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma
-
Fyans PFG, Chatterjee PC, Chatterjee SS. A trial comparing nedocromil sodium (Tilade) and placebo in the management of bronchial asthma. Clin Allergy 1986; 16: 505-511.
-
(1986)
Clin Allergy
, vol.16
, pp. 505-511
-
-
Fyans, P.F.G.1
Chatterjee, P.C.2
Chatterjee, S.S.3
-
39
-
-
0015920875
-
Aerosol beclomethasone dipropionate: A dose response study in chronic bronchial asthma
-
Gaddie J, Reid IW, Skinner C, Petrie GR, Sinclair DJM, Palmer KNV. Aerosol beclomethasone dipropionate: a dose response study in chronic bronchial asthma. Lancet 1973; ii: 280-281.
-
(1973)
Lancet
, vol.2
, pp. 280-281
-
-
Gaddie, J.1
Reid, I.W.2
Skinner, C.3
Petrie, G.R.4
Sinclair, D.J.M.5
Palmer, K.N.V.6
-
40
-
-
0029837804
-
Fluticasone propionate compared with theophylline for mild-to-moderate asthma
-
Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ. Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Ann Allergy Asthma Immunol 1996; 77: 112-118.
-
(1996)
Ann Allergy Asthma Immunol
, vol.77
, pp. 112-118
-
-
Galant, S.P.1
Lawrence, M.2
Meltzer, E.O.3
Tomasko, M.4
Baker, K.A.5
Kellerman, D.J.6
-
41
-
-
0003736036
-
-
NIH Publication No. 95-3659. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute
-
Global Initiative for Asthma. Global strategy for asthma management and prevention. NIH Publication No. 95-3659. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, 1995.
-
(1995)
Global Strategy for Asthma Management and Prevention
-
-
-
42
-
-
0344569677
-
Inhaled fluticasone propionate (FP) 500 μg/day improves asthma-specific quality of life more than triamcinolone acetonide (TAA) 800 μg/day or placebo (PL)
-
Goodwin B, Cox FM, Noonan M, Rogenes P, Wisniewski M. Inhaled fluticasone propionate (FP) 500 μg/day improves asthma-specific quality of life more than triamcinolone acetonide (TAA) 800 μg/day or placebo (PL). Eur Resp J 1996a; 9 (Suppl 23): 80s.
-
(1996)
Eur Resp J
, vol.9
, Issue.23 SUPPL.
-
-
Goodwin, B.1
Cox, F.M.2
Noonan, M.3
Rogenes, P.4
Wisniewski, M.5
|